image credit: Unsplash

FDA COVID-19 Update

April 20, 2020


The following are some of the U.S. FDA’s actions taken, as of April 17, in its ongoing response effort to the COVID-19 pandemic:

  • The National Institutes of Health (NIH) and the Foundation for the NIH announced a public-private partnership with the FDA and others to speed the development of COVID-19 vaccine and treatment options. The Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership also includes the U.S. Centers for Disease Control and Prevention, the European Medicines Agency, the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, as well as more than a dozen biopharmaceutical companies.

Read More on Contract Pharma